Curriculum
Course Description
This presentation from the USP Excipient Stakeholder Forum covers the industry’s perspective on atypical actives, including definitions, regulatory and compendial concerns, GMPs, supply chain issues and risk management. Challenges, opportunities and proposed next steps are discussed.
Access Duration:Access to this course expires 6 months from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.